• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M .

作者信息

Andreica Ioana, Kiefer David, Rezniczek Guenther A, Jast Robert, Buehring Bjoern, Kiltz Uta, Baraliakos Xenofon, Braun Juergen

机构信息

Rheumazentrum Ruhrgebiet, Herne, Nordrhein-Westfalen, Germany.

Ruhr-Universität Bochum, Bochum, Nordrhein-Westfalen, Germany.

出版信息

Ann Rheum Dis. 2022 Oct;81(10):e189. doi: 10.1136/annrheumdis-2020-218609. Epub 2020 Jul 30.

DOI:10.1136/annrheumdis-2020-218609
PMID:32732243
Abstract
摘要

相似文献

1
Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M .对吉安弗兰切斯科·M.所著的《风湿性疾病患者新冠病毒肺炎住院相关特征：来自新冠病毒肺炎全球风湿病联盟医生报告登记处的数据》的评论
Ann Rheum Dis. 2022 Oct;81(10):e189. doi: 10.1136/annrheumdis-2020-218609. Epub 2020 Jul 30.
2
COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco . Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience' by Khan 'Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M by Andreica and 'COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs' by Ansarin .COVID-19全球风湿病联盟注册研究、抗白细胞介素-6治疗、共同决策与患者预后。对以下文章的回应：吉安弗朗切斯科撰写的“风湿病患者COVID-19住院相关特征：来自COVID-19全球风湿病联盟医生报告注册研究的数据”；汗撰写的“在临床试验出现之前，在严重COVID-19伴高炎症中同情使用托珠单抗——一家地区综合医院的真实世界经验”；安德烈伊卡撰写的“对吉安弗朗切斯科·M撰写的‘风湿病患者COVID-19住院相关特征：来自COVID-19全球风湿病联盟医生报告注册研究的数据’的评论”；安萨林撰写的“接受免疫调节药物治疗的系统性自身免疫疾病患者的COVID-19结局” 。
Ann Rheum Dis. 2022 Oct;81(10):e191. doi: 10.1136/annrheumdis-2020-218713. Epub 2020 Aug 12.
3
Comment on: 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco .对吉安弗兰切斯科所著的《风湿病患者中与COVID-19住院相关的特征：来自COVID-19全球风湿病联盟医生报告登记处的数据》的评论
Ann Rheum Dis. 2023 Mar;82(3):e75. doi: 10.1136/annrheumdis-2020-218497. Epub 2020 Jul 21.
4
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco . Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases.关于吉安弗兰切斯科所著《风湿性疾病患者新冠病毒肺炎住院相关特征：来自新冠病毒肺炎全球风湿病联盟医生报告登记处的数据》的通信。在风湿性肌肉骨骼疾病患者中，疾病活动度而非糖皮质激素治疗，可能与新冠病毒肺炎的严重程度相关。
Ann Rheum Dis. 2022 Nov;81(11):e222. doi: 10.1136/annrheumdis-2020-218845. Epub 2020 Sep 7.
5
Correspondence to: 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco .致信：吉安弗兰切斯科所著的《风湿病患者中与 COVID-19 住院相关的特征：来自 COVID-19 全球风湿病联盟医生报告登记处的数据》
Ann Rheum Dis. 2023 Jun;82(6):e140. doi: 10.1136/annrheumdis-2020-218733. Epub 2020 Aug 19.
6
Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco . Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases' by Giollo .风湿性疾病活动、糖皮质激素使用与2019冠状病毒病。对以下内容的回应：“关于‘风湿性疾病患者2019冠状病毒病住院相关特征：来自2019冠状病毒病全球风湿病联盟医生报告登记处的数据’的通信”，作者为詹弗兰切斯科。乔洛指出：“在风湿性肌肉骨骼疾病患者中，疾病活动而非糖皮质激素治疗可能与2019冠状病毒病的严重程度相关。”
Ann Rheum Dis. 2022 Nov;81(11):e223. doi: 10.1136/annrheumdis-2020-218910. Epub 2020 Sep 7.
7
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco . Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience.关于吉安弗兰切斯科的《风湿性疾病患者新冠病毒肺炎住院相关特征：来自新冠病毒肺炎全球风湿病联盟医生报告登记处的数据》的通信。在临床试验出现之前，托珠单抗在伴有高度炎症的重症新冠病毒肺炎中的同情用药——一家地区综合医院的真实世界经验。
Ann Rheum Dis. 2022 Oct;81(10):e188. doi: 10.1136/annrheumdis-2020-218528. Epub 2020 Jul 30.
8
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M . The impact of cardiovascular comorbidity on COVID-19 infection in a large cohort of rheumatoid arthritis patients.关于吉安弗兰切斯科·M. 的《风湿性疾病患者新冠病毒肺炎住院相关特征：来自新冠病毒肺炎全球风湿病联盟医生报告登记处的数据》的通信。心血管合并症对一大群类风湿关节炎患者新冠病毒感染的影响。
Ann Rheum Dis. 2023 Jul;82(7):e159. doi: 10.1136/annrheumdis-2020-218813. Epub 2020 Sep 15.
9
Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry' by Arnaud and Devilliers.对阿诺德和德维利耶斯的《关于“风湿性疾病患者中与COVID-19相关死亡的因素：COVID-19全球风湿病联盟医生报告登记处的结果”的通信》的回复
Ann Rheum Dis. 2023 May;82(5):e114. doi: 10.1136/annrheumdis-2021-220058. Epub 2021 Feb 18.
10
Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry'.关于“风湿性疾病患者中与COVID-19相关死亡的因素：COVID-19全球风湿病联盟医生报告登记处的结果”的通信
Ann Rheum Dis. 2023 May;82(5):e113. doi: 10.1136/annrheumdis-2021-220037. Epub 2021 Feb 18.

引用本文的文献

1
Are patients with rheumatic diseases on immunosuppressive therapies protected against preventable infections? A cross-sectional cohort study.风湿免疫病患者接受免疫抑制治疗后能否预防可预防性感染？一项横断面队列研究。
RMD Open. 2021 Apr;7(1). doi: 10.1136/rmdopen-2020-001499.
2
Inflammatory arthritis in patients with COVID-19.COVID-19 患者的炎症性关节炎。
Transl Res. 2021 Jun;232:49-59. doi: 10.1016/j.trsl.2021.02.010. Epub 2021 Feb 21.
3
[Threat of a SARS-CoV-2 endemic in a large hospital specialized in rheumatic diseases-relative all clear through consistent testing].
[一家大型风湿病专科医院出现新冠病毒地方性流行的威胁——通过持续检测基本排除风险]
Z Rheumatol. 2021 Feb;80(1):45-47. doi: 10.1007/s00393-021-00959-8. Epub 2021 Jan 25.